EFFECTIVENESS AND SAFETY OF NEW DIRECT ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C INFECTION: PRELIMINARY DATA IN A COINFECTED HIV/HCV POPULATION